JP2020524524A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020524524A5 JP2020524524A5 JP2020516379A JP2020516379A JP2020524524A5 JP 2020524524 A5 JP2020524524 A5 JP 2020524524A5 JP 2020516379 A JP2020516379 A JP 2020516379A JP 2020516379 A JP2020516379 A JP 2020516379A JP 2020524524 A5 JP2020524524 A5 JP 2020524524A5
- Authority
- JP
- Japan
- Prior art keywords
- cflar
- hla
- expression level
- melanoma
- normalized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762511058P | 2017-05-25 | 2017-05-25 | |
| US62/511,058 | 2017-05-25 | ||
| PCT/US2018/033658 WO2018217627A1 (en) | 2017-05-25 | 2018-05-21 | Methods for melanoma detection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020524524A JP2020524524A (ja) | 2020-08-20 |
| JP2020524524A5 true JP2020524524A5 (https=) | 2021-07-26 |
| JP7227964B2 JP7227964B2 (ja) | 2023-02-22 |
Family
ID=62620988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020516379A Active JP7227964B2 (ja) | 2017-05-25 | 2018-05-21 | 黒色腫の検出方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20180340934A1 (https=) |
| EP (1) | EP3631017B1 (https=) |
| JP (1) | JP7227964B2 (https=) |
| KR (1) | KR102763004B1 (https=) |
| CN (1) | CN111315897B (https=) |
| AU (1) | AU2018273844B2 (https=) |
| BR (1) | BR112019024481A2 (https=) |
| CA (1) | CA3064732A1 (https=) |
| DK (1) | DK3631017T3 (https=) |
| ES (1) | ES2920288T3 (https=) |
| IL (1) | IL270787B2 (https=) |
| MX (1) | MX2019014026A (https=) |
| PL (1) | PL3631017T3 (https=) |
| WO (1) | WO2018217627A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102763004B1 (ko) | 2017-05-25 | 2025-02-04 | 리퀴드 바이옵시 리서치 엘엘씨 | 흑색종의 검출 방법 |
| MX2022004372A (es) | 2019-10-10 | 2022-07-27 | Liquid Biopsy Res Llc | Composiciones, métodos y kits para la estabilización de muestras biológicas y de arn. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1838732A4 (en) * | 2005-01-07 | 2010-07-14 | Univ Johns Hopkins | BIOMARKER FOR MELANOME |
| US7615349B2 (en) * | 2006-09-07 | 2009-11-10 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Melanoma gene signature |
| AU2007347118B2 (en) * | 2006-11-03 | 2012-11-01 | Baylor Research Institute | Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis |
| US20100248225A1 (en) * | 2006-11-06 | 2010-09-30 | Bankaitis-Davis Danute M | Gene expression profiling for identification, monitoring and treatment of melanoma |
| US20110070582A1 (en) | 2008-11-03 | 2011-03-24 | Source Precision Medicine, Inc. d/b/d Source MDX | Gene Expression Profiling for Predicting the Response to Immunotherapy and/or the Survivability of Melanoma Subjects |
| EP2488874A4 (en) * | 2009-10-13 | 2013-08-14 | Univ Johns Hopkins | BIOMARKERS FOR THE IDENTIFICATION OF MELANOMOTUM CELLS |
| US20140045915A1 (en) | 2010-08-31 | 2014-02-13 | The General Hospital Corporation | Cancer-related biological materials in microvesicles |
| EA201590041A1 (ru) * | 2012-07-03 | 2015-04-30 | Ратиофарм Гмбх | Твердая форма холиновой соли вемурафениба |
| EP3194618B1 (en) * | 2014-09-15 | 2021-04-21 | Clifton Life Sciences LLC | Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm |
| KR102763004B1 (ko) | 2017-05-25 | 2025-02-04 | 리퀴드 바이옵시 리서치 엘엘씨 | 흑색종의 검출 방법 |
-
2018
- 2018-05-21 KR KR1020197038285A patent/KR102763004B1/ko active Active
- 2018-05-21 ES ES18731615T patent/ES2920288T3/es active Active
- 2018-05-21 CA CA3064732A patent/CA3064732A1/en active Pending
- 2018-05-21 DK DK18731615.3T patent/DK3631017T3/da active
- 2018-05-21 US US15/984,935 patent/US20180340934A1/en not_active Abandoned
- 2018-05-21 JP JP2020516379A patent/JP7227964B2/ja active Active
- 2018-05-21 PL PL18731615.3T patent/PL3631017T3/pl unknown
- 2018-05-21 BR BR112019024481-6A patent/BR112019024481A2/pt unknown
- 2018-05-21 MX MX2019014026A patent/MX2019014026A/es unknown
- 2018-05-21 CN CN201880049298.1A patent/CN111315897B/zh active Active
- 2018-05-21 WO PCT/US2018/033658 patent/WO2018217627A1/en not_active Ceased
- 2018-05-21 EP EP18731615.3A patent/EP3631017B1/en active Active
- 2018-05-21 AU AU2018273844A patent/AU2018273844B2/en active Active
-
2019
- 2019-11-20 IL IL270787A patent/IL270787B2/en unknown
-
2021
- 2021-09-30 US US17/490,433 patent/US12399179B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220396842A1 (en) | Method for using gene expression to determine prognosis of prostate cancer | |
| EP3189156B1 (en) | Thyroid cancer diagnosis by dna methylation analysis | |
| JP5415963B2 (ja) | 新しい癌マーカー | |
| JP2017528164A5 (https=) | ||
| JP2018524972A (ja) | 肺癌の診断または検出のための方法及び組成物 | |
| JP2021514624A5 (https=) | ||
| JP2017060515A (ja) | 遺伝子の発現を分析することによって患者における癌の転帰を予測するための方法 | |
| JP2024523848A (ja) | 癌検出方法、キットおよびシステム | |
| JP2021511057A5 (https=) | ||
| US20210277479A1 (en) | Risk scores based on human phosphodiesterase 4 d variant 7 expression | |
| CN107858434B (zh) | lncRNA在肝癌诊断以及预后预测中的应用 | |
| CA2989480C (en) | Kit and method for the diagnosis/prognosis of idiopathic scoliosis | |
| JP2020528274A5 (https=) | ||
| JP2020524524A5 (https=) | ||
| CN106550605B (zh) | 用于预测心力衰竭和心肌梗塞患者中疾病进展的线粒体非编码rna | |
| CN104498495A (zh) | 前列腺癌标志物lncRNA MALAT-1及其应用 | |
| JP2019512212A (ja) | 活動性結核を検出するための方法 | |
| HK1253908A1 (en) | Method for the diagnosis/prognosis of adolescent idiopathic scoliosis | |
| JP2017529094A5 (https=) | ||
| WO2018123764A1 (ja) | 神経芽腫の微小残存病変を評価するために用いられる試薬、およびそれを用いた生体試料の分析方法 | |
| US20220372573A1 (en) | Methods and systems for detection of kidney disease or disorder by gene expression analysis | |
| IL317236A (en) | Predicting peptide receptor radiotherapy using gene expression testing | |
| CN111315897B (zh) | 用于黑素瘤检测的方法 | |
| JP2024170603A (ja) | 免疫チェックポイント阻害療法からの利益を予測する方法 | |
| WO2017102902A1 (en) | Micrornas as predictive biomarkers of type 1 diabetes |